Related Experiment Video

Updated: May 28, 2026

Development of New Therapeutic Applications Using Microfluidics
08:56

Development of New Therapeutic Applications Using Microfluidics

Published on: October 1, 2007

Bridging the gap between translational research and clinical application

William R Miller1, Alexey A Larionov

  • 1University of Edinburgh, Western General Hospital, Edinburgh, UK. w.r.miller@ed.ac.uk

Journal of the National Cancer Institute. Monographs
|November 2, 2011
PubMed

Insights

Primary systemic therapy offers insights into tumor behavior but faces challenges in clinical application. Overcoming these hurdles is key for practical use in patient care.

Area of Science:

  • Oncology
  • Clinical Research
  • Translational Medicine

Background:

  • Primary systemic therapy (PST) is crucial for understanding tumor biology and treatment response.
  • Current PST protocols generate valuable data but present practical implementation challenges.

Purpose of the Study:

  • To explore the challenges in obtaining and utilizing data from primary systemic therapy in clinical practice.
  • To identify strategies for improving the practical application of PST-derived information.

Main Methods:

  • Review of existing PST protocols and their data collection methods.
  • Analysis of barriers to integrating PST data into routine clinical decision-making.
  • Discussion of potential solutions and future research directions.

Main Results:

  • Significant knowledge gaps exist regarding the practical application of PST data.
  • Challenges include data acquisition, standardization, and interpretation within the clinical workflow.
  • Effective utilization requires overcoming logistical and technical hurdles.

Conclusions:

  • While PST provides fundamental insights, its clinical utility is hampered by practical challenges.
  • Addressing these challenges is essential to translate research findings into improved patient management and outcomes.

More Related Videos

Working with Human Tissues for Translational Cancer Research07:48

Working with Human Tissues for Translational Cancer Research

Published on: November 26, 2015

Related Concept Videos

Improving Translational Accuracy02:07

Improving Translational Accuracy

Base complementarity between the three base pairs of mRNA codon and the tRNA anticodon is not a failsafe mechanism. Inaccuracies can range from a single mismatch to no correct base pairing at all. The free energy difference between the correct and nearly correct base pairs can be as small as 3 kcal/ mol. With complementarity being the only proofreading step, the estimated error frequency would be one wrong amino acid in every 100 amino acids incorporated. However, error frequencies observed in...
Improving Translational Accuracy02:07

Improving Translational Accuracy

Base complementarity between the three base pairs of mRNA codon and the tRNA anticodon is not a failsafe mechanism. Inaccuracies can range from a single mismatch to no correct base pairing at all. The free energy difference between the correct and nearly correct base pairs can be as small as 3 kcal/ mol. With complementarity being the only proofreading step, the estimated error frequency would be one wrong amino acid in every 100 amino acids incorporated. However, error frequencies observed in...
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Translational Regulation01:29

Translational Regulation

Translational regulation in prokaryotes ensures efficient protein synthesis by controlling ribosome access to mRNA. This regulation is mediated by secondary RNA structures, including translational riboswitches, RNA thermometers, and small RNAs (sRNAs), which respond to intracellular and environmental signals to modulate gene expression.Translational RiboswitchesRiboswitches in the leader region of mRNAs can regulate translation by altering the accessibility of the Shine-Dalgarno (SD) sequence,...